Abata Therapeutics
Latest round
- Series A
Last raised
- Jun 2021
Total raised
- $45M
Investors
- 6
About Abata Therapeutics
Established in 2021 by Richard Ransohoff (CMO) and others and based in Massachusetts, US, Abata Therapeutics, Inc. operates as a developer of cell therapy by using regulatory T cells to treat serious autoimmune and inflammatory diseases. The company was launched by Third Rock Ventures. In August 2024, Abata Therapeutics, Inc. The company develops tissue-specific therapies for autoimmune diseases, focusing on conditions with unmet needs such as progressive multiple sclerosis (MS) and type 1 diabetes (T1D). The firm's lead program targets progressive MS, which is a debilitating autoimmune disease that damages the central nervous system (CNS). Abata’s TCR-Treg therapy addresses the core pathology of MS, where existing treatments fall short by selectively targeting and modulating the immune response. In addition, the company is advancing a program for T1D, targeting patients with a specific genetic HLA haplotype. This program aims to intervene early in the disease process to preserve beta-cell function and prevent the onset of insulin dependence.
Who invested in Abata Therapeutics
6 investors across 1 round
See all investors in Abata Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jun 23, 2021
Amount
$45M
Investors
Questions about Abata Therapeutics
Who invested in Abata Therapeutics?
Abata Therapeutics has 6 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Abata Therapeutics raised?
Abata Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Abata Therapeutics last raise money?
Abata Therapeutics's most recent round on record is a Series A, in Jun 2021.
What does Abata Therapeutics do?
Established in 2021 by Richard Ransohoff (CMO) and others and based in Massachusetts, US, Abata Therapeutics, Inc.
Where is Abata Therapeutics headquartered?
Abata Therapeutics is headquartered in Watertown, US.
Which VCs invest in companies like Abata Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Abata Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Abata Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.